Matthew Warren > Bristows LLP > London, England > Lawyer Profile

Bristows LLP
100 VICTORIA EMBANKMENT
LONDON
EC4Y 0DH
England

Living Wage

Work Department

Commercial IP

Position

Matthew is the head of Bristows’ Commercial IP group and advises on transactions involving the development, exploitation and transfer of intellectual property rights.

His scientific background is of particular assistance when negotiating and advising on transactions involving new technologies. He has advised on a number of successful global licensing programmes for the exploitation of new technologies and has also advised in relation to international patent pooling arrangements.

He works across many sectors but has particular experience in the pharmaceuticals, biotechnology, medtech, electronics, software, telecoms, petrochemical, cleantech and other industrial sectors. Matthew’s experience in negotiating commercial contracts for pharmaceutical, biotechnology and medtech clients includes technology licensing agreements, R&D collaboration agreements, drug development and licensing agreements, clinical trial agreements and option agreements for licences. He also advises pharmaceutical and biotechnology clients on the commercial and intellectual property law aspects of manufacturing, distribution, co-promotion and marketing agreements.

The negotiation of agreements to resolve disputes involving intellectual property rights forms a significant part of Matthew’s practice. This has included global settlements to end litigation across multiple jurisdictions involving complex intellectual property, licensing and financial arrangements.

He advises on the intellectual property aspects of setting up joint ventures and other collaborations including in relation to the ownership and licensing of intellectual property and improvements. Matthew has particular experience advising on intellectual property issues relating to technical standards including FRAND terms for licensing standard essential patents.

Matthew was involved in setting up the IP Transactions Course at the UCL Faculty of Laws, University College London and lectures on the course.

Career

Qualified 1991
Partner at Bristows LLP since 1998

Education

Imperial College, London University (Bsc Physics);
Bristol University (Diploma in Intellectual Property Law and Practice)

Lawyer Rankings

London > TMT (technology, media and telecoms) > Intellectual property: patents (contentious and non-contentious)

(Leading partners)

Matthew WarrenBristows LLP

Fielding an extensive and varied patents practice that is noted for its ‘fantastic technical ability’, Bristows LLP demonstrates considerable prowess across a myriad of technical sectors, encompassing telecoms, pharmaceuticals, biotech, and electronics, to name a few. On the contentious side, the team frequently manages FRAND and biologics mandates, while on the non-contentious side, the team excels in collaboration and licensing deals, as well as the IP elements of significant corporate deals. Three experienced practitioners lead the team: Robert Burrows, who leverages his knowledge in genetics to assist clients in the life sciences industry, seasoned litigator Andrew Bowler, who routinely coordinates global strategies in the space, and Richard Dickinson, who frequently handles matters pertaining to transactional and advisory work. Liz Cohen possesses experience representing clients up to the Supreme Court, and James Boon operates for a litany of clients in the context of cross-border litigation. Myles Jelf bolsters the group with his strengths in hi-tech patent litigation, while Matthew Warren retains an extensive transactional practice. Other names to note include Claire Smith, Richard Pinckney, Dominic Adair, Brian Cordery, and Greg Bacon.

London > Corporate and commercial > Commercial contracts

(Leading partners)

Matthew Warren  – Bristows LLP

Noted for its ‘significant experience‘ and ‘pragmatic advice‘, Bristows LLP is adept at handling day-to-day operational contracts, as well as contracts related to large commercial transactions. The group is prolific in the pharmaceutical and IP industries, calling upon the biochemistry knowledge of practice head Richard Dickinson, who brings significant expertise in commercial transactions to clients. Major clients include international conglomerates, indicative of the group’s cross-border expertise and strength in advising clients with large international portfolios which require advice on large-scale strategic collaboration. Other key contacts include Matthew WarrenClaire Smith, who assists with bespoke supply and distribution agreements; and Ellen Lambrix and Paul Jordan, who are notably skilled in advising on manufacturing agreements and logistics agreements, respectively, for large retailers.